A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer ...
A common response between two types of immune cells during a COVID-19 infection and after initial vaccinations can cause ...
An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results.
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
Melanoma is the deadliest form of skin cancer. A new vaccine-drug combo could slash recurring cases - An estimated 112,000 ...
The combination of a vaccine and a drug, which both harness the immune system to attack cancer cells, has proven successful ...
Patients with deadly skin cancer could soon benefit from a revolutionary vaccine that has been shown to slash the risk of ...
A personalized mRNA vaccine may change melanoma treatment, with 70% of patients cancer-free after 5 years. Discover how this ...
The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results